Work

Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation

Year: 2021

Type: article

Source: Biochemical Pharmacology

DOI: 10.1016/j.bcp.2021.114844

Authors: Erin T. Larragoite, Racheal A. Nell, Laura J. Martins, Louis R. Barrows, Vicente Planelles, Adam M. Spivak

Institution: University of Utah

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Doris Duke Charitable Foundation, University of Pennsylvania, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences

Awards: G1389033727, BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy, G3450047942, Discovery and Characterization of Latency-Reversing Compounds, G4195755252, Preclinical Development of Ingenol and HDACi Toward HIV Eradication, Utah Center for Clinical and Translational Science, The Effects of ART on Platelets and HIV-Associated Thrombosis, Preclinical Development of Ingenol and HDACi Toward HIV Eradication, Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts, Training Program in Microbial Pathogenesis

OpenAlex ID: W3215679604

FWCI: 0.418

Cites: 69

Cited by: 9

Related to: 10